MANÜ Telehealth Tirzepatide Review: Cost, Named 503A Sourcing & Honest Verdict (2026)

MANÜ Telehealth: compounded GLP-1s advertised from about $4-5/day, exclusively sourced from US 503A pharmacies, with per-dose pricing gated behind account signup rather than published openly. Every fact here comes from the company's own published program.

What MANÜ Telehealth is

MANÜ Telehealth is a US online platform, offering compounded GLP-1 weight-loss medication including injectable tirzepatide and semaglutide, plus add-ons like MIC Ultraburn and NAD+ injections. An online intake is reviewed by a licensed clinician before treatment begins.

What MANÜ Telehealth costs

Compounds are advertised from roughly $4-5/day — but exact per-dose pricing isn't published; you have to log in or sign up to see it, and MANÜ doesn't publish a firm price until after the intake.

The brand-vs-compounded question

MANÜ Telehealth dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

MANÜ Telehealth's real strengths: compounds exclusively from US 503A pharmacies, 100% online with free discreet shipping and no insurance needed, and add-on options like MIC Ultraburn and NAD+ for patients wanting more than a single GLP-1. The trade-offs: per-dose pricing is gated behind login/signup rather than public, state availability changes and is only confirmed at signup, and as with any compounded product, it is not FDA-evaluated. As with any GLP-1 program, confirm your actual price and state coverage before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

MANÜ Telehealth's exclusively US 503A sourcing is a genuine positive, but the gated per-dose pricing means you can't compare its real cost against other providers without signing up first. For a provider with fully published pricing and no login gate, compare it against CoreAge Rx or Luvo Health. See our best tirzepatide providers ranking for the full field.